| (19) |
 |
|
(11) |
EP 1 629 852 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
28.04.2010 Bulletin 2010/17 |
| (43) |
Date of publication A2: |
|
01.03.2006 Bulletin 2006/09 |
| (22) |
Date of filing: 11.08.2005 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
|
Designated Extension States: |
|
AL BA HR MK YU |
| (30) |
Priority: |
17.08.2004 US 602501 P
06.12.2004 US 5618
|
| (71) |
Applicant: T&A Pharma Pty. Limited |
|
Castlecrag NSW 2068 (AU) |
|
| (72) |
Inventors: |
|
- Vancaillie, Thierry G.
Castlecrag
New South Wales 2068 (AU)
- Hewitt, Alan Ernest
Windsor Downs
New South Wales 2754 (AU)
|
| (74) |
Representative: Käck, Jürgen |
|
Kahler Käck Mollekopf
Vorderer Anger 239
86899 Landsberg/Lech
86899 Landsberg/Lech (DE) |
|
| |
|
| (54) |
Topical anaesthesia formulation for bodily cavities |
(57) For use in bodily cavities, a topical anesthetic combination having a pH adjusted
to optimize the effectiveness of the anesthetic, a viscosity appropriate to displace
tissue debris and enhance retention, and addition of chemicals which increase the
bio-availability of the anesthetic molecules.